Stock Picks

Disclaimer: This Blog/Person is not a Registered Investment Advisor or a Broker / Dealer. Readers are advised that this website is issued solely for information purposes and does not guarantee its accuracy.

My Photo
Name:
Location: Los Angeles, California, United States

I first became interested in stocks at the age of 14 and I have been an intern for three summers at a large Investment banking firm on the West Coast. I do research on stocks all the time and I also enjoy basketball,hockey and football

Tuesday, September 27, 2005

OOO-LA-LA CAFFEINE

What else can I say about a company whose revenues exceed SIX billion dollars yearly and quarterly revenue growth of 21 percent. The company has over 300 Million in cash and only THREE Million in debt. The company’s products are in high demand, although there is fierce competition brewing. This company makes the best tasting coffee drinks and beverages in the world, Yes! you guessed it, STARBUCKS. Starbucks is a great company, they are now expanding in Japan and Asia which would tap a huge market. Personally, I happen to go there because I think it makes a much better product than The Coffee Bean and Tea Leaf and other smaller coffee emporiums such as PEETS. Anyway, back to the more important stuff, Starbucks should generate much more revenue from its expansion into Japan and the rest of Asia. The company is tackling a part of the world that has lived on drinking teas for thousands of years, but this marketing strategy is brilliant and successful. Hopefully, with new, innovative and tasty beverages and products on the horizon, Starbucks will continue to be THE leader in the coffee and beverage department as it continues to expand in the global markets.

Price now: $48.55

Price target: $62

Tuesday, September 20, 2005

GNTA, STEM, ELN

Genta, StemCells Inc., and of course Elan, what is there to say about these three companies. Well on the one hand Genta has cost shareholders millions of dollars over the years, which is also true for Elan. Genta had a promising drug a couple years back called Genasense which was up for regulatory approval and was rejected and the stock went from around $18 to now $1.59. Then we have STEM, or StemCells Inc., they are just a speculative Stemcell company with lots of promise and no revenue and they run out of cash quickly...anyways I speculated on this stock and it made me alot of money during election time when this topic was hot. Then we have Elan. Elan is a good company with one drug behind it and if it doesnt get approved with this re-filing then it will suffer dearly...anyways I gotta run, but I am also gonna throw in IMCL ...They filed for regulatory approval of Erbitux for head and neck cancers which could generate millions more. prices now.... GNTA $1.59 price target $5.50..... STEM $5.53 price target $11...ELN $8.49 price target $22 pending on approval...hopefully.... and IMCL $29.80...price target....$45

Thursday, September 01, 2005

Brav-NO! for BRAVO FOODS

I was doing some research on this company, Bravo Foods and I realized one thing...okay, sure they have some really good licensing deals with Marvel, and good distributing deals with major retailers, but I just went to the store and bought one of their milk shakes and I have to say it was the single, most disgusting thing I think I have ever tasted. Plus, I just got off the phone with the CEO of the company, Mr. Roy G. Warren, and he was extremely rude to me. Who does he think he is? He hung up on me because I asked him, "As the CEO of Bravo Foods, Do you taste every single product that you market and distribute?" And he replied, "Are You implying that you dislike our product?" and I said "I have siblings and they have some mixed feelings." To which he responded, "Do you think I would market a product that I personally did not like?" AND HE HUNG UP ON ME!!!!!!! HOW RUDE! I was just asking a simple question! IS THAT THE WAY TO HANDLE THE SITUATION MR. WARREN?!!?!?!?! WOULD YOUR SHAREHOLDERS APPRECIATE THE WAY YOU RESPOND TO QUESTIONS YOU DISLIKE? YOU SHOULD READ THE SARBANES-OXLEY ACT OF 2002.


Free Hit Counter